Correction to: Polatuzumab Vedotin: First Global Approval
- PMID: 31617142
- PMCID: PMC6825632
- DOI: 10.1007/s40265-019-01214-w
Correction to: Polatuzumab Vedotin: First Global Approval
Abstract
The article Polatuzumab Vedotin: First Global Approval, written by Emma D. Deeks, was originally published Online First without Open Access. After publication in volume 79, issue 13, pages 1467-1475 Roche/GCC requested that the article be Open Choice to make the article an open access publication. Post-publication open access was funded by Roche/GCC. The article is forthwith distributed under the terms of the Creative Commons Attribution-NonCommercial.
Erratum for
-
Polatuzumab Vedotin: First Global Approval.Drugs. 2019 Sep;79(13):1467-1475. doi: 10.1007/s40265-019-01175-0. Drugs. 2019. PMID: 31352604 Free PMC article. Review.
Publication types
LinkOut - more resources
Full Text Sources
